- Home
- ADVB vs CLGN Comparison
ADVB vs CLGN Comparison
Compare ADVB & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADVB
- CLGN
- Stock Information
- Founded
- ADVB 2014
- CLGN 2004
- Country
- ADVB United States
- CLGN Israel
- Employees
- ADVB N/A
- CLGN N/A
- Industry
- ADVB Medical Specialities
- CLGN Industrial Specialties
- Sector
- ADVB Health Care
- CLGN Health Care
- Exchange
- ADVB Nasdaq
- CLGN Nasdaq
- Market Cap
- ADVB 36.1M
- CLGN 22.1M
- IPO Year
- ADVB 2025
- CLGN N/A
- Fundamental
- Price
- ADVB $1.03
- CLGN $3.18
- Analyst Decision
- ADVB
- CLGN Strong Buy
- Analyst Count
- ADVB 0
- CLGN 2
- Target Price
- ADVB N/A
- CLGN $11.50
- AVG Volume (30 Days)
- ADVB 197.6K
- CLGN 165.3K
- Earning Date
- ADVB 01-01-0001
- CLGN 05-28-2025
- Dividend Yield
- ADVB N/A
- CLGN N/A
- EPS Growth
- ADVB N/A
- CLGN N/A
- EPS
- ADVB N/A
- CLGN N/A
- Revenue
- ADVB N/A
- CLGN $2,472,000.00
- Revenue This Year
- ADVB N/A
- CLGN $2,177.67
- Revenue Next Year
- ADVB N/A
- CLGN $56.52
- P/E Ratio
- ADVB N/A
- CLGN N/A
- Revenue Growth
- ADVB N/A
- CLGN N/A
- 52 Week Low
- ADVB $0.86
- CLGN $1.55
- 52 Week High
- ADVB $4.10
- CLGN $5.63
- Technical
- Relative Strength Index (RSI)
- ADVB N/A
- CLGN 59.91
- Support Level
- ADVB N/A
- CLGN $1.90
- Resistance Level
- ADVB N/A
- CLGN $4.98
- Average True Range (ATR)
- ADVB 0.00
- CLGN 0.40
- MACD
- ADVB 0.00
- CLGN 0.25
- Stochastic Oscillator
- ADVB 0.00
- CLGN 47.52
About ADVB Advanced Biomed Inc. Common Stock
Advanced Biomed Inc operates through its subsidiaries that are responsible for the main operation and the design and development of the company's primary technologies and products. It has been focusing on the integration of multiple interdisciplinary technologies and established its microfluidic technology platform. Utilizing the physical and molecular biological characteristics of tumor cells, the company has developed various advanced and original research through the joint application of semiconductor technology and biotechnology. devices, A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.